Article Text

Prolongation of epidural anaesthesia in dogs with bupivacaine in a lipid emulsion
  1. C. Franquelo, BPharm1,
  2. J. Manubens, BVM1,
  3. C. Cristòfol, PhD1,
  4. J. E. Valladares, PhD1,
  5. M. Arboix, PhD1 and
  6. A. Toledo, PhD2
  1. 1 Divisiò de Farmacologia, Facultat de Veterinària, UAB, 08193 Bellaterra, Spain
  2. 2 B. Braun-Medical SA, Carretera de Terrassa 121, 08191 Rubi, Spain


An aqueous solution and a lipid emulsion of bupivacaine were administered epidurally in doses of 1.8 mg/kg to six beagle dogs following a randomised two-phase crossover design. The aqueous solution was absorbed rapidly and the mean (sd) peak venous plasma concentration of bupivacaine, 1.4 (0.4) μg/ml, was detected after five minutes. After administration of the lipid emulsion, the peak plasma concentration of bupivacaine, 0.6 (0.2) μg/ml, was detected after 30 minutes. The mean (sd) t½β of the aqueous preparation was 149.1 (32.6) minutes, and of the lipid emulsion 119.2 (34.0) minutes. Both preparations had a similar bioavailability. The mean time to the onset of motor block after the administration of the aqueous solution, 2.3 (2.2) minutes, was significantly shorter (P=0.028) than after the administration of the lipid emulsion, 9.4 (1.9) minutes, and the duration of the motor block induced by the lipid emulsion, 217.6 (26.2) minutes, was significantly longer (P=0.043) than for the aqueous solution, 158 (48.8) minutes. During anaesthesia, the plasma concentrations of bupivacaine ranged between 1.3 and 0.2 μg/ml. Non-significant changes in systolic blood pressure and heart rate were observed which coincided with the peak plasma concentrations of bupivacaine.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.